QL
RARE icon

Quarry LP’s Ultragenyx Pharmaceutical RARE Stock Holding History

Quarry LP’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$445K Buy
21,250
+16,250
+325% +$366K 0.08% 174
2025
Q4 		$115K Buy
5,000
+4,890
+4,445% +$161K 0.02% 398
2025
Q3 		$3.31K Buy
+110
New +$3.3K ﹤0.01% 1919
2025
Q1 		– Sell
-2,000
Closed -$84.1K – 1945
2024
Q4 		$84.1K Buy
+2,000
New +$99.2K 0.01% 507
2024
Q2 		– Sell
-2,500
Closed -$117K – 2042
2024
Q1 		$117K Buy
2,500
+300
+14% +$14.2K 0.02% 216
2023
Q4 		$105K Sell
2,200
-2,000
-48% -$77.5K 0.02% 191
2023
Q3 		$150K Buy
+4,200
New +$166K 0.03% 168

Other funds holding RARE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Quarry LP's RARE Position: Q1 2026 in Review

Quarry LP increased its Ultragenyx Pharmaceutical (RARE) stake by 325% in Q1 2026, buying an estimated $366K and bringing the position to 21,250 shares worth $445K. The position accounts for 0.08% of the portfolio, ranked #174.

Quarry LP first reported a position in RARE in Q3 2023 and has held it in 7 quarters since. 295 funds tracked by Wall St. Rank hold RARE as of Q1 2026.

  • Quarry LP held 21,250 shares of Ultragenyx Pharmaceutical worth $445K as of Q1 2026.
  • Quarry LP bought 16,250 Ultragenyx Pharmaceutical shares in Q1 2026, an estimated $366K.
  • Ultragenyx Pharmaceutical made up 0.08% of Quarry LP's portfolio in Q1 2026, its #174 holding.
  • Quarry LP first reported a position in Ultragenyx Pharmaceutical in Q3 2023 and has held it in 7 quarters since.
  • 295 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q1 2026.

Based on Quarry LP's 13F filing for Q1 2026, filed 15 May 2026.